If you’re a long-time T-Mobile subscriber on a plan you took out years ago, the company may have some bad news for you. The carrier is closing what it says are more than 1,100 different legacy “plan ...

The CI/CD Pipeline Is Your Compliance Engine. Here's How to Wire It Up. You're a few weeks into your SOC 2 process. An auditor you're paying by the hour, is asking you to manually export six months of ...

Microsoft has announced the public preview of Azure Container Apps Sandboxes. This new ARM resource type is Microsoft.App/SandboxGroups runs untrusted code generated ...

AI-powered tools can help teams accelerate processes throughout the software development life cycle. Here’s how to make them work. If the supreme goal for software development teams is to get ...

Have you ever used Google to find out how to do something? If so, the first several links are likely to be YouTube videos. I appreciate a good explainer video, but they take time to watch. Video is ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

GitLab 19.0 extends agentic AI across the full software lifecycle with its Duo Agent Platform, adds SBOM-based dependency scanning, and supports Claude Opus 4.7 and Gemini models. The release targets ...

As tools like Claude Code get better, more and more developers are happy to hand off coding tasks to them. The way software gets built has changed for good. The vibes were strong at Code with Claude, ...

For the past several years, application security has been organized around a relatively stable model: developers write code, pipelines build and test it, and runtime controls attempt to catch what ...

TL;DR: Stop chasing thousands of "toast" alerts. Join experts from Wiz to learn how hackers connect tiny flaws to build a "Lethal Chain" to your data—and how to break it. Register for the Strategic ...

Therorna to Showcase Clinical-Ready Circular RNA in vivo CAR-T and CircRNA Pipeline at the 2026 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting TI-0032 first-in-human study initiated; ...

Deal builds upon UCB’s position as a leader in immunology innovation and expands capabilities in next-generation biologics with potential for immune reset Candid’s lead asset, cizutamig, a bispecific ...